🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🆕 EAUPodcast! 🎧 Listen to a discussion between Dr. Bertolo and Prof. Autorino on the key features of multi-port and single-port surgery for #RCC, as well as considerations for selecting the most suitable patients for each approach. #AUA2025 👉 uroweb.org/education-even…

Published by Università di Verona #Urology team in BJUI Compass a comparative #analysis of CT scans and 3D virtual models for preoperative #renal #tumor assessments, demonstrating that 3D models significantly increased interobserver agreement, highlighting their potential to improve

Would renaming Gleason Score 6 prostate cancer as non-cancer lead to better outcomes? Listen to our latest podcast with Prof. Scott Eggener Scott Eggener as we explore this important and timely debate.European Association of Urology (EAU) Society of Urologic Oncology European Society of Residents in Urology EAU Young Academics

📹 In this expert video discussion, UROONCO PCa Assoc. Prof. Pawel Rajwa is joined by Prof. Gert De Meerleer & Dr. Roderick van den Bergh to talk about the management of biochemical recurrence in #prostatecancer. Watch here 👇 prostate.uroonco.uroweb.org/video/treatmen…

📹 A promising step forward for #kidneycancer screening? In this video discussion, UROONCO RCC chief editor Dr. Carmen Mir talks to Dr. Teele Kuusk on screening for renal cell carcinoma. Watch and learn more here 👇 kidney.uroonco.uroweb.org/video/screenin…

📰 Is RAPN best for recovery? Read the UROONCO RCC Article of the Month featuring the final results of the OpeRa trial: open vs. robotic-assisted partial nephrectomy. Plus, expert commentary from Dr. Teele Kuusk. Learn more here 👇 kidney.uroonco.uroweb.org/publication/op…

📰 New #UROONCO BCa Article of the Month: The RAZOR trial shows comparable outcomes for robot-assisted vs. open radical cystectomy. In commentary, Dr. Grobet-Jeandin noted that surgical approach choice should reflect expertise & experience. 👇 bladder.uroonco.uroweb.org/publication/co…

📹 Tune in to this video discussion between UROONCO RCC associate editor Dr. 𝙍𝙞𝙘𝙘𝙖𝙧𝙙𝙤 𝘽𝙚𝙧𝙩𝙤𝙡𝙤 MD PhD and Dr. Pieter De Backer , talking about auxiliary technologies in robotic surgery and the use of AI for intra-operative visual guidance. Learn more here kidney.uroonco.uroweb.org/video/auxiliar…👇 #kidneycancer

📹 Should we still perform #lymphadenectomy? Find out what the experts think in this panel discussion between UROONCO PCa chief editor Dr. Giancarlo Marra, Prof. Karim Touijer, Prof. Declan Murphy and Dr. Giorgio Gandaglia. Learn more here 👇 prostate.uroonco.uroweb.org/video/lymphade…

📰 UROONCO PCa Article of the Month: A ctDNA analysis from the TheraP trial sheds light on biomarkers predicting treatment response in mCRPC. Prof. Claudia Kesch ’s commentary states that findings lay groundwork for a more personalised LuPSMA approach.👇 prostate.uroonco.uroweb.org/publication/lu…

‼️new study by Università di Verona #urology team‼️ We explored effects of early vs delayed ureteral ligation during #RARC: early ligation associated with ⬆️ risk of functional decline, with significantly ⬆️ chance of ≥25% reduction in eGFR and eGFR <60 ml/min (HR 10.3 and 7.3, p<0.04)

New in the PRAISE-U #UROwebinar series! How is MRI-first screening transforming early PCa detection? Explore: ✔️ Impact on biopsy rates ✔️ Diagnostic accuracy ✔️ Clinical integration in Europe ➕ a spotlight on AI in MRI interpretation Register now 👇 webinars.uroweb.org/EAU/webinars/1…

🧾 Cheat Sheet on Follow-up for NMIBC 🔹 Risk-based surveillance 🔹 Lifelong follow-up for high-risk patients 🔹 Role of cytology & markers 🔍 No substitute for cystoscopy Download Cheat Sheet: uroweb.org/guidelines/non… #BladderCancer #NMIBC #EAUguidelines

Kicking off the #UROonco25 with some exciting Crossfires 🔥: ➡️ MRI first or still PSA for screening? ➡️ Systematic or perilesional, + targeted biopsies? ➡️ Active surveillance for ISUP 2 PCa? ➡️ Is lymph node dissection here to stay—forever?

💡 Stay ahead in Von Hippel-Lindau (VHL) management! Join our new #UROwebinar, which offers essential updates on current standards, innovations, and practical decision-making across specialties. Register now and claim your CME credit 👇 webinars.uroweb.org/EAU/webinars/1… Alessandro Larcher

We've just finished an insightful and productive Day 2 at #UROonco25 in Seville, Spain. ✔️The day was filled with plenty of engaging discussions with leading experts in #ProstateCancer #BladderCancer #KidneyCancer #RareCancers

Our team is in Sevilla for #UROonco25 📩 #NMIBC Deintensify LG Biomarkers to ⬇️ cystoscopy in HG #MIBC ctDNA is the future #UTUC Tailored patient care Go for kidney-sparing treatment European Association of Urology (EAU) EAU Edu Platform UROONCO EAU Young Academics

Are we ready for ARPI alone therapy in mCSPC? Is a non-inferiority trial needed? Great lecture by tombal at #UROonco25 in Sevilla but the debate is still open... European Association of Urology (EAU) European Urology OncoDaily OncoAlert UroFocus Alessandro Volpe Morgan Roupret

#UROONCO25 : Very happy to share my tips ans trick for robot-assisted neobladder formation after radical cystectomy during this amazing congress ! EAU Edu Platform UROONCO European Association of Urology (EAU)

📰 RCC Article of the Month: Phase 2 trial shows SBRT can be an effective option for cT1a RCC in frail patients (95% local control, 96% 3-yr PFS/CSS). Genomic profiling may guide precision radiotherapy. Read article, plus commentary by Dr. 𝙍𝙞𝙘𝙘𝙖𝙧𝙙𝙤 𝘽𝙚𝙧𝙩𝙤𝙡𝙤 MD PhD 👇 kidney.uroonco.uroweb.org/publication/st…